General Information of the Compound
| Compound ID |
CP0056416
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(E)-1-[4-(3-ethynylanilino)-7,8-dihydropyrimido[5,4-g][1,4]benzoxazin-6-yl]-4-piperidin-1-ylbut-2-en-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H27N5O2
|
||||||||||||||||||
| Molecular Weight |
453.546
|
||||||||||||||||||
| Canonical SMILES |
O=C(\C=C\CN1CCCCC1)N1CCOc2cc3ncnc(Nc4cccc(c4)C#C)c3cc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H27N5O2/c1-2-20-8-6-9-21(16-20)30-27-22-17-24-25(18-23(22)28-19-29-27)34-15-14-32(24)26(33)10-7-13-31-11-4-3-5-12-31/h1,6-10,16-19H,3-5,11-15H2,(H,28,29,30)/b10-7+
Show/Hide
|
||||||||||||||||||
| InChIKey |
CBDFEHZTEPLMIJ-JXMROGBWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000157 | NCI-H1975 | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 870 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|